Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery
- Conditions
- Otorhinolaryngologic Diseases
- Interventions
- Device: FlosealDevice: SurgifloDevice: Algosteril
- Registration Number
- NCT03243344
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
This study evaluates the efficiency and the cost of three medical devices and the abstention of the use of specific product for the post-operative haemostasis in endonasal surgery .
- Detailed Description
Surgiflo® is a matrix of haemostatic frost of porcine protein origin is the coverage of the post-operative bleeding of which one of the indications is in endonasal surgery.
Floseal® is a haemostatic frost(gel) containing of the thrombin.
Algosteril® is a lint tent of arginate of calcium.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 571
- endonasal surgery schedule
- Surgical indications:
hypertrophic rhinitis, repeated or chronic infections, extraction of foreign body, polyposes naso-sinusal, benign tumors limited to the nasal pit and in sine,
- Pregnant Woman
- Disorder of the haemostasis known or disrupted preoperative biological balance assessment
- Use of treatment disrupting the blood coagulation (anti platelet, anti vitamin K, AINS)
- Unchecked HTA by the treatment and/or preoperative > mmHg 160/90
- Surgical Act including a septoplasty
- malignant tumoral surgical Indication, or mild overtaking the naso-sinusial system
- Dacryocystorhinostomy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Floseal Floseal Using Floseal® (Absorbable Gelatin Hemostatic) containing human thrombin for the post-operative haemostasis in endonasal surgery Surgiflo Surgiflo Using Surgiflo® (Absorbable Gelatin Hemostatic) for the post-operative haemostasis in endonasal surgery. Algosteril Algosteril Using Algosteril® (Hemostatic Sterile Wick) for the post-operative haemostasis in endonasal surgery
- Primary Outcome Measures
Name Time Method Per-operative hemostasis Hours 0 Time needs to observe hemostasis after the device set up
Hemostasis at the 24th hour Hours 24 * Algosteril arm (after having removed the wick): spontaneous observation of hemostasis in less that 3 min (yes/no) and needs to have a new intervention to stop bleedings (type)
* Surgiflo, Floseal, Abstention arms: time to observe hemostasis if bleedings occurred.Hemostasis in the 6 first hours Hours 6 Number of compresses used from Hours 0 to Hours 6.
Spontaneous hemorrhagic events from Hours 0 to Day 45 number of spontaneous hemorrhagic events.
- Secondary Outcome Measures
Name Time Method Device evaluation by the surgeon Hours 0 subjective assessment of the implementation ease
Preoperative assessment Hours 0 Laboratory tests of hemostasis (platelets, fibrinogen...)